ORAMED PHARMACEUTICALS INC. (ORMP) Shareholders’ equity 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) shareholders’ equity at each fiscal year-end, per SEC filings.
$199.7MFY2025 · since FY2016: $26.2M → $199.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $199.7M | — |
| FY2023 | $163.8M | +7.9% |
| FY2022 | $151.8M | +31.1% |
| FY2021 | $115.8M | +252.1% |
| FY2020 | $32.9M | +69.5% |
| FY2019 | $19.4M | -37.7% |
| FY2018 | $31.1M | +61.7% |
| FY2017 | $19.2M | -26.5% |
| FY2016 | $26.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice